KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 159 filers reported holding KITE PHARMA INC in Q2 2015. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $14,276,000 | -9.5% | 285,518 | -16.9% | 4.88% | -14.8% |
| Q1 2016 | $15,770,000 | -38.9% | 343,503 | -18.0% | 5.72% | -32.9% |
| Q4 2015 | $25,815,000 | +23.5% | 418,935 | +11.6% | 8.53% | +31.3% |
| Q3 2015 | $20,907,000 | -14.3% | 375,476 | -6.1% | 6.50% | -8.5% |
| Q2 2015 | $24,388,000 | +12.6% | 400,000 | +6.5% | 7.10% | -27.4% |
| Q1 2015 | $21,666,000 | – | 375,623 | – | 9.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |